There has been no better time than the present for women in the field of oncology, yet even with all of the hard-fought advances women in medicine have made over the last 40 years, challenges stemming from internalized biases at the personal and institutional level persist.
Nov 28, 2016
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs. Indeed, understanding and making meaningful changes to health...
Dec 06, 2016
Survival rates for many types of cancers have continued to improve over the past several decades, contributing to a growing number of long-term cancer survivors. With longer survival, attention to...
Nov 28, 2016
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid...
Nov 21, 2016
Many of the couples that I see in my practice grow closer after the diagnosis and treatment of cancer. But for others, the experience of serious illness exposes existing weak points in their...
Nov 21, 2016
Since the U.S. presidential election I have spoken with family and friends, many of whom who did not vote as I had, and you know what, they are still the same people they were before the election.
Raising Awareness About Breast Health, Tobacco Control, and HPV Vaccination in High Schools in Beirut, Lebanon
Nov 14, 2016
Dr. Nagi S. El-Saghir, Dr. Rita Saroufim, and Dr. Sarah Daouk helped high school students put their science lessons into real-world context during a presentation on breast cancer awareness.
Oct 31, 2016
Hope springs eternal in the Brazilian economy and health care system, with cautious optimism for gains in oncology care.
Latest Comments & Discussions
Read more to answer the following questions: Recognize the clinical characteristics and outcomes for patients with FLT3 mutations? Describe the role of FLT3 inhibitors for the initial treatment of AML? Understand the role of gene mutations, including CLT3, in the pathologic classification of...
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs. Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.
Dr. Meadows will receive the award and deliver a keynote lecture at the 2017 Cancer Survivorship Symposium in San Diego.
Many of the couples that I see in my practice grow closer after the diagnosis and treatment of cancer. But for others, the experience of serious illness exposes existing weak points in their relationship.
Read more to answer the following questions: Is further tissue needed to confirm radiologically presumed metastatic disease or for repeat HER2 testing? What systemic therapy option would you recommend for confirmed HER2 negative metastatic gastric cancer?